Funding
← Back to your selection

NAVER D2SF

Activity from announced rounds

Activity in this selectionHealthtech

NAVER D2SF is NAVER’s startup investment organization, identified through official materials for ImpriMed and NdotLight.

Recorded funding activity

ImpriMed combines live-cell drug testing with clinical data. NdotLight generates simulation-ready 3D data, while F4GE structures factory information for industrial buyers. The organization retains its identity separately from NAVER Ventures and the parent.

Sources
Rounds participated in
3
Confirmed lead rounds
0
2 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$10M
1 disclosed · full round size, not this investor’s share

By stage

Undisclosed3

By primary sector

Healthtech3

By country

South Korea2
United States1

Rounds

3 in this selection
ImpriMed

A precision-oncology service that tests live cancer cells against drugs and uses clinical data to predict which treatments may work best for each patient.

$10MSeries A2 bridge
Participant
Soundable Health

Develops AI-powered acoustic analysis for clinical-grade diagnostics through everyday devices

UndisclosedUndisclosed
Role not disclosed
Nuvilab

Develops AI-powered nutrition analytics solution for healthcare

UndisclosedUndisclosed
Role not disclosed